Terbinafine-induced subacute cutaneous lupus erythematosus
Authors:
- Gisela BonsmannGBGisela Bonsmann
- Meinhard SchillerMSMeinhard Schiller
- Thomas A. LugerTLThomas A. Luger
- Sonja StänderSSSonja Ständer
- 1 June 2001
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 44 (6) , 925-931
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Is systemic autoimmune disease a risk factor for terbinafine-induced erythema multiforme?British Journal of Dermatology, 2000
- Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicityClinical and Experimental Immunology, 1999
- Terbinafine: An updateJournal of the American Academy of Dermatology, 1997
- Significance of the anti-Ro(SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue diseaseJournal of the American Academy of Dermatology, 1996
- Drug-Related LupusDrug Safety, 1991
- Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvinJournal of the American Academy of Dermatology, 1989
- Clinical pharmacokinetics of terbinafine (Lamisil)Clinical and Experimental Dermatology, 1989
- Drug-Related LupusNew England Journal of Medicine, 1988
- Mechanism of drug-induced lupusChemical Research in Toxicology, 1988
- DemonstrationenDermatology, 1979